EMCDDA Document Library

Displaying 1 - 10 of 27

COVID-19 and the drug supply chain: from production and trafficking to use (UNODC)

May 2020

This report examines the impact of the COVID-19 pandemic on the illicit drug market. It was prepared by the UNODC Global Research Network and is based on the most recent data from government authorities, open sources, including the media, and the network of UNODC field offices. It should be noted...

Dutch national update on harm reduction and coronavirus (3 april 2020)

April 2020

This document provides an update on harm reduction activities during the pandemic in the Nethderlands.

How Harm Reducers Cope with the COVID-19 Pandemic in Europe? (Drug Reporter)

March 2020

On this info page Drugreporter updates you about how European harm reduction service providers mitigate the risks of COVID-19 infections and protect their clients, who are among the most at risk groups of our societies. This article is being constantly updated as  more information is received.

Conclusions of the WHO international meeting on prisons and health, Lisbon 2017

February 2018

The World Health Organization (WHO) international meeting on prisons and health, held in Lisbon, Portugal, on 11–12 December 2017, brought together more than 100 experts in the field of prison and public health from 30 countries worldwide. The meeting participants propose the following conclusions...

EU Justice and Home Affairs agencies’ cooperation in 2017

December 2017

The Justice and Home Affairs (JHA) agencies’ network was established in 2006 and is made up of nine European Union (EU) agencies (1). The network plays key operational, coordination and advisory roles in the implementation of EU priorities and objectives in the areas of freedom, security and...

Note on guidelines and tools for the evaluation of national drug policy (EMCDDA Scientific Committee)

January 2017

This note was prepared by the Scientific Committee of the European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) as input to action 47 of the EU Action Plan on Drugs 2013-2016. Action 47 calls upon the European Commission, EU Member States and the EMCDDA to promote scientific evaluations...

Annual expert meeting on Drug-related deaths (DRD) and Drug-related infectious diseases (DRID) – Preliminary summary and highlights of the meeting

November 2014

Two EMCDDA expert meetings, dedicated to the agency’s drug-related deaths and mortality among drug users indicator (DRD) and the drug-related infectious diseases indicator (DRID), were held in Lisbon from 15–17 October. This three-day event gathering the DRD and DRID key indicator networks offered...

Memorandum of Understanding on cooperation between EUROJUST and the EMCDDA

July 2014

EMCDDA contribution towards a methodological framework for monitoring drugs and prison in Europe

February 2013

This is the revised EMCDDA contribution towards a methodological framework for monitoring drugs and prison in Europe presented during the Horizontal Working Party on Drugs meeting held on 6 February 2013.

Working arrangement between the EMA and the EMCDDA (2012)

September 2012

Loading